全文获取类型
收费全文 | 283470篇 |
免费 | 25006篇 |
国内免费 | 10849篇 |
专业分类
耳鼻咽喉 | 3216篇 |
儿科学 | 5960篇 |
妇产科学 | 3589篇 |
基础医学 | 37135篇 |
口腔科学 | 8179篇 |
临床医学 | 27042篇 |
内科学 | 39895篇 |
皮肤病学 | 6584篇 |
神经病学 | 15409篇 |
特种医学 | 7558篇 |
外国民族医学 | 152篇 |
外科学 | 26148篇 |
综合类 | 43406篇 |
现状与发展 | 66篇 |
一般理论 | 2篇 |
预防医学 | 9322篇 |
眼科学 | 5464篇 |
药学 | 22242篇 |
98篇 | |
中国医学 | 15933篇 |
肿瘤学 | 41925篇 |
出版年
2024年 | 221篇 |
2023年 | 4306篇 |
2022年 | 5847篇 |
2021年 | 10443篇 |
2020年 | 10165篇 |
2019年 | 9546篇 |
2018年 | 9504篇 |
2017年 | 10281篇 |
2016年 | 11030篇 |
2015年 | 11708篇 |
2014年 | 18492篇 |
2013年 | 21753篇 |
2012年 | 16519篇 |
2011年 | 18228篇 |
2010年 | 15129篇 |
2009年 | 14242篇 |
2008年 | 14566篇 |
2007年 | 15245篇 |
2006年 | 13729篇 |
2005年 | 12445篇 |
2004年 | 10646篇 |
2003年 | 9379篇 |
2002年 | 7670篇 |
2001年 | 6640篇 |
2000年 | 5490篇 |
1999年 | 4573篇 |
1998年 | 3696篇 |
1997年 | 3426篇 |
1996年 | 2915篇 |
1995年 | 2929篇 |
1994年 | 2511篇 |
1993年 | 2046篇 |
1992年 | 1699篇 |
1991年 | 1599篇 |
1990年 | 1266篇 |
1989年 | 1161篇 |
1988年 | 1099篇 |
1987年 | 895篇 |
1986年 | 801篇 |
1985年 | 1027篇 |
1984年 | 913篇 |
1983年 | 646篇 |
1982年 | 666篇 |
1981年 | 557篇 |
1980年 | 464篇 |
1979年 | 369篇 |
1978年 | 242篇 |
1977年 | 180篇 |
1976年 | 151篇 |
1975年 | 71篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
目的 评价多功能套针浮刺疗法对神经根型颈椎病的临床疗效。方法 选取256例神经根型颈椎病患者,按随机数字表法分为观察组与对照组各128例。观察组应用多功能套针浮刺疗法进行干预,对照组为常规针刺治疗。两组患者均治疗7天。分别于治疗前后观察两组患者的简化McGill疼痛问卷(SF-MPQ)、国际标准颈椎功能障碍指数(NDI)和田中靖久颈椎病症状20分法量表评分,并于治疗结束后3个月观察复发率。结果 两组患者治疗后的SF-MPQ量表评分、NDI量表评分及田中靖久颈椎病症状20分法评分与治疗前相比均有改善(P<0.05),且观察组优于对照组(P<0.05);两组患者于治疗后3个月随访,SF-MPQ量表评分与治疗后相比均有改善,且观察组优于对照组(P<0.05);观察组临床疗效总有效率为96.88%,愈显率为81.25%;对照组总有效率为78.13%,愈显率为46.88%,观察组优于对照组(P<0.05)。结论 应用多功能套针浮刺疗法治疗神经根型颈椎病临床疗效显著,见效较快,可有效降低其复发率,且作用稳定,效果持久,值得临床推广应用。 相似文献
4.
5.
Kevin Kyung Ho Choi Santosh Sanagapalli 《World journal of gastrointestinal oncology》2022,14(3):568-586
Barrett's esophagus (BE) is the precursor to esophageal adenocarcinoma (EAC). Progression to cancer typically occurs in a stepwise fashion through worsening dysplasia and ultimately, invasive neoplasia. Established EAC with deep involvement of the esophageal wall and/or metastatic disease is invariably associated with poor long-term survival rates. This guides the rationale of surveillance of Barrett’s in an attempt to treat lesions at an earlier, and potentially curative stage. The last two decades have seen a paradigm shift in management of Barrett’s with rapid expansion in the role of endoscopic eradication therapy (EET) for management of dysplastic and early neoplastic BE, and there have been substantial changes to international consensus guidelines for management of early BE based on evolving evidence. This review aims to assist the physician in the therapeutic decision-making process with patients by comprehensive review and summary of literature surrounding natural history of Barrett’s by histological stage, and the effectiveness of interventions in attenuating the risk posed by its natural history. Key findings were as follows. Non-dysplastic Barrett’s is associated with extremely low risk of progression, and interventions cannot be justified. The annual risk of cancer progression in low grade dysplasia is between 1%-3%; EET can be offered though evidence for its benefit remains confined to highly select settings. High-grade dysplasia progresses to cancer in 5%-10% per year; EET is similarly effective to and less morbid than surgery and should be routinely performed for this indication. Risk of nodal metastases in intramucosal cancer is 2%-4%, which is comparable to operative mortality rate, so EET is usually preferred. Submucosal cancer is associated with nodal metastases in 14%-41% hence surgery remains standard of care, except for select situations. 相似文献
6.
7.
《European journal of surgical oncology》2022,48(5):1062-1067
BackgroundSurgical resection is recommended for patients with resectable acinar cell carcinoma (ACC). The aim of this study was to investigate the clinical characteristics and surgical outcomes of resectable ACC in comparison to pancreatic ductal adenocarcinoma (PDAC).MethodA retrospective analysis was performed on all patients who consecutively underwent radical resection with pathologically confirmed ACC and PDAC from December 2011 to December 2018. Clinicopathologic characteristics and follow-up information were analyzed. A 1:3 propensity score matching (PSM) method was used to minimize the bias between ACC and PDAC.ResultsA total of 26 patients with ACC and 1351 with PDAC were included. Compared to PDAC, ACC tended to be larger (4.5 vs. 3.0 cm; p < 0.001) and more frequently located in the pancreatic body/tail (61.5% vs. 36.6%, p = 0.009), with lower total bilirubin levels, lower neutrophil lymphocyte ratio (NLR) levels and lower carbohydrate antigen 19-9 (CA19-9) levels and carcinoembryonic antigen (CEA) levels. There was no difference in postoperative morbidities in patients with ACC and PDAC. The median OS and RFS were longer in ACC when compared to PDAC (OS: 43.5 mo vs. 19.0 mo, p = 0.004; RFS: 24.5 mo vs. 11.6 mo, p = 0.023). After the 1:3 PSM, ACC remained to be a better histological type for OS (p = 0.024), but had comparable RFS with PDAC (p = 0.164).ConclusionPatients with ACC after radical resection had better OS than that with PDAC. However, ACC is also an aggressive tumor with a similar trend of RFS with PDAC after the matching, necessitating the multidisciplinary treatment for resectable ACC disease. 相似文献
8.
外泌体是一类直径为30~100 nm的圆盘囊泡,其内包含许多组分,诸如复杂RNA和蛋白质等,主要参与细胞间的信号转导。肿瘤相关巨噬细胞(tumor-associated macrophages,TAMs)是肿瘤微环境中普遍存在的巨噬细胞,通过对肿瘤生长、免疫逃逸、侵袭和转移、耐药性等多方面的作用影响肿瘤进程。外泌体在肿瘤相关巨噬细胞的招募、极化及抗肿瘤免疫调控等方面发挥着重要的调节功能。同时,TAMs以外泌体为媒介作用于肿瘤细胞,从而构成了外泌体、TAMs与肿瘤细胞之间相互作用的调控通路。综上所述,本文旨在阐明肿瘤细胞与TAMs之间,以外泌体为“桥梁”相互影响的潜在机制,以及靶向肿瘤细胞和TAMs来源的外泌体在恶性肿瘤治疗中的展望。 相似文献
9.
10.
Mahmut Gümüş MD Chieh-I Chen MPH Cristina Ivanescu PhD Saadettin Kilickap MD Igor Bondarenko MD Mustafa Özgüroğlu MD Miranda Gogishvili MD Haci M. Turk MD Irfan Cicin MD James Harnett PharmD Vera Mastey MS Ulrike Naumann MS Matthew Reaney MS Gerasimos Konidaris MS Medha Sasane PhD Keri J. S. Brady PhD Siyu Li PhD Giuseppe Gullo MD Petra Rietschel MD Ahmet Sezer MD 《Cancer》2023,129(1):118-129